Daily News Podcast

9-valent HPV vaccine approved for 27-45 age group


 

The FDA has expanded the approval of the vaccine marketed as Gardasil-9 to include men and women between 27 and 45 years old. Also today, the allergen of the year may be closer than you think, encourage influenza vaccination in pregnant women, and the truth about sunscreens.
Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

ADHD: The big picture
MDedge Hematology and Oncology
Arginine deficiency implicated in novel hemorrhagic fever fatality
MDedge Hematology and Oncology
Experts advocate for flu vaccination
MDedge Hematology and Oncology
Get on top of home BP monitoring
MDedge Hematology and Oncology
Researchers share Nobel Prize for cancer immunotherapy discoveries
MDedge Hematology and Oncology
Aspirin for the elderly: what to do
MDedge Hematology and Oncology
Neurological disease and aging
MDedge Hematology and Oncology
PCV13 for older adults
MDedge Hematology and Oncology
Sexual assault, harassment linked to depression
MDedge Hematology and Oncology
How to vaccinate patients on biologics
MDedge Hematology and Oncology